Clinical Trials Logo

Clinical Trial Summary

This study will assess the renal hemodynamic effect of RLX030 infusion in subjects with chronic heart failure. In addition safety and effects on renal function and biomarkers will be assessed.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01546532
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 2
Start date February 2012
Completion date December 2012

See also
  Status Clinical Trial Phase
Recruiting NCT02892747 - Dietetics Education Focused on Malnutrition Prevention N/A
Completed NCT01581008 - Improving Symptoms and Quality of Life in Chronic Heart Failure: Pilot Study N/A
Recruiting NCT06248658 - Assessment of the Impact of Clinical Decision Support Systems Included in Electronic Health Records
Completed NCT02884206 - Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction Phase 3
Enrolling by invitation NCT04790214 - Effect of a Cardiac Rehabilitation Program on Chronic Heart Failure Patients in Yaoundé, Cameroon N/A
Completed NCT02807857 - A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary Care N/A
Active, not recruiting NCT04041193 - An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B) N/A
Completed NCT01197313 - Depression and Quality of Life in Chronic Heart Failure Patients and the Caregivers N/A
Completed NCT04225728 - Evaluation on Performance and Oxydative Stress in Patient With Iron deficIency and Stable Heart Failure Study Phase 4